Post-extractive Alveolus Regeneration
Influence of PRGF and PRF on Post-extractive Alveolus Regeneration. Randomised Controlled Trial
1 other identifier
interventional
43
1 country
1
Brief Summary
Healing of post-extraction alveolus is a complex process that involves soft and hard tissues regeneration. Pain, swelling, difficulty of opening the mouth, delayed healing of bone tissue, alveolitis and horizontal or vertical resorption of bone tissue are the main problems that have impact on consequent treatment. Blood concentrates PRGF (plasma rich in growth factors) and PRF (platelet-rich fibrin), which are rich in growth factors, create better conditions for post-extraction alveolus healing and enhance quality of soft tissues and bone regeneration. Our study objective was to compare physiological healing of post-extraction zone, PRF and PRGF induced changes of healing process. Methods that we used: 43 patients were randomly divided into 3 groups: I control group - lower molar extraction and filling of post-extraction alveolus with hemostatic sponge containing gentamicin, II group - post-extraction alveolus is filled PRGF and III group - post-extraction alveolus is filled with PRF. Bone regeneration was evaluated in CBCT scans after 1 month. Pain was evaluated using visual analogical scale (VAS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 29, 2020
CompletedFirst Submitted
Initial submission to the registry
February 16, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedFebruary 21, 2021
February 1, 2021
4 months
February 16, 2021
February 17, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Post operative pain
Pain was evaluated using visual analogical scale (VAS). Pacients selected number from 0 to 10, there accordingly 0 - no pain, 5 - moderate pain and 10 - worst pain.
First day after surgery.
Post operative pain
Pain was evaluated using visual analogical scale (VAS). Pacients selected number from 0 to 10, there accordingly 0 - no pain, 5 - moderate pain and 10 - worst pain.
Seventh day after surgery.
Bone regeneration
Bone regeneration was evaluated in CBCT scans. In CBCT scans (Ez3D Plus Professional Ver.1.2.6.1) immediately after surgery horizontal (mm) and vertical (mm) dimensions of alveolar ridge were measured.
Immediately after surgery.
Bone regeneration
Bone regeneration was evaluated in CBCT scans. In CBCT scans (Ez3D Plus Professional Ver.1.2.6.1) 1 month after surgery horizontal (mm) and vertical (mm) dimensions of alveolar ridge were measured. Also, horizontal (mm), vertical (mm) and diagonal (mm) dimensions of primary bone tissue formed in post-extraction alveolus in 1 month.
1 month after surgery.
Study Arms (3)
Control group
ACTIVE COMPARATORLower molar extraction and filling of post-extraction alveolus with hemostatic sponge containing gentamicin.
PRGF group
EXPERIMENTALPost-extraction alveolus is filled with PRGF.
PRF group
EXPERIMENTALPost-extraction alveolus is filled with PRF.
Interventions
Tooth extraction and alveolus regeneration with autologous blood concentrate.
Eligibility Criteria
You may qualify if:
- Patients who need lower molar extraction
- Patients who belong to working age group (18-50 years)
You may not qualify if:
- Pregnant women and postmenopausal women
- Children and older than 50 years old patients
- Oncological diseases, undergone chemotherapy and radiation therapy
- Chronic diseases
- Hormonal imbalances
- Somatic symptom disorder
- Osteoporosis, osteonecrosis
- Taking bisphosphonates, antidepressants, psychotropic drugs
- Smoking
- Psychologically dissabled patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lithuanian University of Health Sciences
Kaunas, Lithuania
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jan Pavel Rokicki
Oral surgeon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 16, 2021
First Posted
February 21, 2021
Study Start
September 1, 2019
Primary Completion
December 29, 2019
Study Completion
January 29, 2020
Last Updated
February 21, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share